Cargando…

HIV-1 Enhancing Effect of Prostatic Acid Phosphatase Peptides Is Reduced in Human Seminal Plasma

We recently reported that HIV-1 infection can be inhibited by innate antimicrobial components of human seminal plasma (SP). Conversely, naturally occurring peptidic fragments from the SP-derived prostatic acid phosphatase (PAP) have been reported to form amyloid fibrils called “SEVI” and enhance HIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Martellini, Julie A., Cole, Amy L., Svoboda, Pavel, Stuchlik, Olga, Chen, Li-Mei, Chai, Karl X., Gangrade, Bhushan K., Sørensen, Ole E., Pohl, Jan, Cole, Alexander M.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024420/
https://www.ncbi.nlm.nih.gov/pubmed/21283773
http://dx.doi.org/10.1371/journal.pone.0016285
_version_ 1782196788306903040
author Martellini, Julie A.
Cole, Amy L.
Svoboda, Pavel
Stuchlik, Olga
Chen, Li-Mei
Chai, Karl X.
Gangrade, Bhushan K.
Sørensen, Ole E.
Pohl, Jan
Cole, Alexander M.
author_facet Martellini, Julie A.
Cole, Amy L.
Svoboda, Pavel
Stuchlik, Olga
Chen, Li-Mei
Chai, Karl X.
Gangrade, Bhushan K.
Sørensen, Ole E.
Pohl, Jan
Cole, Alexander M.
author_sort Martellini, Julie A.
collection PubMed
description We recently reported that HIV-1 infection can be inhibited by innate antimicrobial components of human seminal plasma (SP). Conversely, naturally occurring peptidic fragments from the SP-derived prostatic acid phosphatase (PAP) have been reported to form amyloid fibrils called “SEVI” and enhance HIV-1 infection in vitro. In order to understand the biological consequence of this proviral effect, we extended these studies in the presence of human SP. PAP-derived peptides were agitated to form SEVI and incubated in the presence or absence of SP. While PAP-derived peptides and SEVI alone were proviral, the presence of 1% SP ablated their proviral activity in several different anti-HIV-1 assays. The anti-HIV-1 activity of SP was concentration dependent and was reduced following filtration. Supraphysiological concentrations of PAP peptides and SEVI incubated with diluted SP were degraded within hours, with SP exhibiting proteolytic activity at dilutions as high as 1∶200. Sub-physiological concentrations of two prominent proteases of SP, prostate-specific antigen (PSA) and matriptase, could degrade physiological and supraphysiological concentrations of PAP peptides and SEVI. While human SP is a complex biological fluid, containing both antiviral and proviral factors, our results suggest that PAP peptides and SEVI may be subject to naturally occurring proteolytic components capable of reducing their proviral activity.
format Text
id pubmed-3024420
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-30244202011-01-31 HIV-1 Enhancing Effect of Prostatic Acid Phosphatase Peptides Is Reduced in Human Seminal Plasma Martellini, Julie A. Cole, Amy L. Svoboda, Pavel Stuchlik, Olga Chen, Li-Mei Chai, Karl X. Gangrade, Bhushan K. Sørensen, Ole E. Pohl, Jan Cole, Alexander M. PLoS One Research Article We recently reported that HIV-1 infection can be inhibited by innate antimicrobial components of human seminal plasma (SP). Conversely, naturally occurring peptidic fragments from the SP-derived prostatic acid phosphatase (PAP) have been reported to form amyloid fibrils called “SEVI” and enhance HIV-1 infection in vitro. In order to understand the biological consequence of this proviral effect, we extended these studies in the presence of human SP. PAP-derived peptides were agitated to form SEVI and incubated in the presence or absence of SP. While PAP-derived peptides and SEVI alone were proviral, the presence of 1% SP ablated their proviral activity in several different anti-HIV-1 assays. The anti-HIV-1 activity of SP was concentration dependent and was reduced following filtration. Supraphysiological concentrations of PAP peptides and SEVI incubated with diluted SP were degraded within hours, with SP exhibiting proteolytic activity at dilutions as high as 1∶200. Sub-physiological concentrations of two prominent proteases of SP, prostate-specific antigen (PSA) and matriptase, could degrade physiological and supraphysiological concentrations of PAP peptides and SEVI. While human SP is a complex biological fluid, containing both antiviral and proviral factors, our results suggest that PAP peptides and SEVI may be subject to naturally occurring proteolytic components capable of reducing their proviral activity. Public Library of Science 2011-01-20 /pmc/articles/PMC3024420/ /pubmed/21283773 http://dx.doi.org/10.1371/journal.pone.0016285 Text en Martellini et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Martellini, Julie A.
Cole, Amy L.
Svoboda, Pavel
Stuchlik, Olga
Chen, Li-Mei
Chai, Karl X.
Gangrade, Bhushan K.
Sørensen, Ole E.
Pohl, Jan
Cole, Alexander M.
HIV-1 Enhancing Effect of Prostatic Acid Phosphatase Peptides Is Reduced in Human Seminal Plasma
title HIV-1 Enhancing Effect of Prostatic Acid Phosphatase Peptides Is Reduced in Human Seminal Plasma
title_full HIV-1 Enhancing Effect of Prostatic Acid Phosphatase Peptides Is Reduced in Human Seminal Plasma
title_fullStr HIV-1 Enhancing Effect of Prostatic Acid Phosphatase Peptides Is Reduced in Human Seminal Plasma
title_full_unstemmed HIV-1 Enhancing Effect of Prostatic Acid Phosphatase Peptides Is Reduced in Human Seminal Plasma
title_short HIV-1 Enhancing Effect of Prostatic Acid Phosphatase Peptides Is Reduced in Human Seminal Plasma
title_sort hiv-1 enhancing effect of prostatic acid phosphatase peptides is reduced in human seminal plasma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024420/
https://www.ncbi.nlm.nih.gov/pubmed/21283773
http://dx.doi.org/10.1371/journal.pone.0016285
work_keys_str_mv AT martellinijuliea hiv1enhancingeffectofprostaticacidphosphatasepeptidesisreducedinhumanseminalplasma
AT coleamyl hiv1enhancingeffectofprostaticacidphosphatasepeptidesisreducedinhumanseminalplasma
AT svobodapavel hiv1enhancingeffectofprostaticacidphosphatasepeptidesisreducedinhumanseminalplasma
AT stuchlikolga hiv1enhancingeffectofprostaticacidphosphatasepeptidesisreducedinhumanseminalplasma
AT chenlimei hiv1enhancingeffectofprostaticacidphosphatasepeptidesisreducedinhumanseminalplasma
AT chaikarlx hiv1enhancingeffectofprostaticacidphosphatasepeptidesisreducedinhumanseminalplasma
AT gangradebhushank hiv1enhancingeffectofprostaticacidphosphatasepeptidesisreducedinhumanseminalplasma
AT sørensenolee hiv1enhancingeffectofprostaticacidphosphatasepeptidesisreducedinhumanseminalplasma
AT pohljan hiv1enhancingeffectofprostaticacidphosphatasepeptidesisreducedinhumanseminalplasma
AT colealexanderm hiv1enhancingeffectofprostaticacidphosphatasepeptidesisreducedinhumanseminalplasma